KontRASt-03
Novartis
Novartis
National Cancer Institute (NCI)
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Bristol-Myers Squibb
Pfizer
Seagen Inc.
Fate Therapeutics
Tianjin Medical University Cancer Institute and Hospital
Alterome Therapeutics, Inc.
Verastem, Inc.
Novartis
Revolution Medicines, Inc.
Hoffmann-La Roche
University of Chicago
Revolution Medicines, Inc.
Erasca, Inc.
Erasca, Inc.
Eastern Cooperative Oncology Group
Incyte Corporation
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
AstraZeneca
Incyte Corporation
Multitude Therapeutics Inc.
Eli Lilly and Company
Pfizer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Pfizer
Tizona Therapeutics, Inc
Genentech, Inc.
Memorial Sloan Kettering Cancer Center
Institut du Cancer de Montpellier - Val d'Aurelle
University of Wisconsin, Madison
University of Campania Luigi Vanvitelli
Revolution Medicines, Inc.
Gruppo Oncologico Italia Meridionale
M.D. Anderson Cancer Center
Gruppo Oncologico del Nord-Ovest
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Pfizer
Gruppo Oncologico del Nord-Ovest
M.D. Anderson Cancer Center
PAQ Therapeutics, Inc.
Eli Lilly and Company